Updated efficacy and safety data from the AGILE study in patients with newly-diagnosed acute myeloid leukemia treated with ivosidenib plus azacitidine compared to placebo plus azacitidine
Fecha de publicación:
Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- Heuser, M.
- Vives, Polo S.
- Zarzycka, E.
- Wang, J.
- Riva, M.
- Calado, R. T.
- Schuh, A. C.
- Yeh, S. -P
- Hui, J.
- Gianolio, D. A.
- Patel, P.
- Recher, C.
- de Botton, S.
- Doehner, H.
Grupos
Abstract
Abstract no disponible
Filiaciones
Filiaciones no disponibles
Campos de Estudio
Cita
Heuser,M,Montesinos,P,Vives,PS,Zarzycka,E,Wang,J,Riva,M,Calado,RT et al. Updated efficacy and safety data from the AGILE study in patients with newly-diagnosed acute myeloid leukemia treated with ivosidenib plus azacitidine compared to placebo plus azacitidine. ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND:KARGER. 2023 p.p. 95-95.
Portal de investigación